RIDGELAND, Miss.--(BUSINESS WIRE)--Cal-Maine Foods, Inc. (NASDAQ: CALM (“Cal-Maine Foods” or the “Company”), today announced the appointment of Keira Lombardo as the Company's first-ever Chief Strategy Officer (CSO), effective today. The creation of this role underscores Cal-Maine Food's commitment to delivering long-term value through operational excellence, innovation, and deeper stakeholder engagement. As CSO, Lombardo will work with the senior leadership team to further accelerate and shape.

COPENHAGEN, Denmark, August 11, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its second quarter 2025 financial results on Thursday August 14, 2025, before opening of the Nasdaq CM.

- Released positive topline data from the VIRAGE Phase 2b study of VCN-01 (zabilugene almadenorepvec); expanded data to be presented at the European Society for Medical Oncology (ESMO) 2025 Congress in October -

LOS ANGELES, Aug. 11, 2025 (GLOBE NEWSWIRE) -- LiveOne (Nasdaq: LVO), an award-winning, creator-first, music, entertainment, and technology platform, plans to announce its operating and financial results for the first quarter of its fiscal year ending March 31, 2026 (“Q1 Fiscal 2026”) and host an investor webcast to discuss the results on Wednesday, August 13, 2025.

EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today reported Q2 2025 financial results, provided operational highlights and outlined expected upcoming milestones.

HIGH POINT, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes (T1D), today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application directed to compositions of matter of crystalline forms of salts and co-crystals of cadisegliatin. The patent term runs through 2041.

Momentum builds as company expands wellness offerings beyond airports and earns industry recognition Momentum builds as company expands wellness offerings beyond airports and earns industry recognition

LOS ANGELES, Aug. 11, 2025 (GLOBE NEWSWIRE) -- PodcastOne (Nasdaq: PODC), a leading publisher and podcast sales network, plans to announce its operating and financial results for the first quarter of its fiscal year ending March 31, 2026 (“Q1 Fiscal 2026”) and host an investor webcast to discuss the results on Wednesday, August 13, 2025.

DENVER, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Crestone Air Partners (“Crestone”) today announced the formation of Blue Crest Aviation Partners (“Blue Crest”), a new joint venture anchored by funds managed by Blue Owl Capital, Inc. (“Blue Owl”). The platform will seek to acquire mid-life commercial jet aircraft on lease to airlines globally, through a disciplined, income-oriented strategy.

PARSIPPANY, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) today announced financial and operating results for the second quarter ended June 30, 2025, as well as recent business developments.

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a global advisory, broking and solutions company, has today announced the appointment of Nicholas Carbo as Senior Director to its Insurance Consulting & Technology (ICT) business.

FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) announced today the early tender results of the previously announced cash tender offer (the “Tender Offer”) by its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), to purchase any and all of the Issuer's outstanding 5.625% Senior Secured Notes due 2027 (the “2027 Notes”), on the terms and subject to the conditions set forth in the Offer to Purchase, dated July 28, 2025, as ame.

NEW YORK--(BUSINESS WIRE)--WisdomTree today released monthly metrics for July 2025, including assets under management (AUM) and flow data by asset class.

NORWALK, Conn.--(BUSINESS WIRE)--Xerox Holdings Corporation (NASDAQ: XRX) today announced that its President and Chief Operating Officer, John Bruno, has decided to pursue a CEO opportunity outside of Xerox. Bruno, who has served as President and COO since 2022 and as a Xerox Board member since 2024, will remain in his operating role through August 31, and then continue as a member of the Xerox Board of Directors. In his Board member role, he will chair the newly formed Integration Committee, o.

STAMFORD, Conn.--(BUSINESS WIRE)--Pitney Bowes Inc. (NYSE:PBI) (“Pitney Bowes” or, the “Company”) today announced that it completed its previously announced offering (the “Offering”) of $230 million aggregate principal amount of 1.50% convertible senior notes due 2030 (the “Convertible Notes”) in a private placement under the Securities Act of 1933, as amended (the “Securities Act”). The $230 million aggregate principal amount of Convertible Notes sold in the Offering includes $30 million aggre.

PONTE VEDRA, Fla.--(BUSINESS WIRE)---- $CVKD #AFib--Cadrenal Therapeutics reports on Second Quarter 2025 financial results and provides corporate update on strategic clinical trial plans.

TEMPE, Ariz.--(BUSINESS WIRE)--Benchmark Electronics, Inc. (NYSE: BHE) proudly announces the successful completion of the delivery of 24 Mobile Vehicle Surveillance Systems with Radar (MVSS-R) for U.S. Customs and Border Protection (CBP) and the Federal Aviation Administration (FAA). This delivery, completed on time and within budget, reaffirms Benchmark's commitment to excellence in developing and deploying advanced surveillance technology that leverages artificial intelligence (AI), radar, an.

BOISE, Idaho, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) (the “Company”) today announced that it is updating its revenue, gross margin, operating expense, and EPS guidance for the fourth quarter of fiscal 2025, which ends August 28, 2025. The Company previously provided guidance for revenue of $10.7 billion ± $300 million, non-GAAP gross margins of 42.0% ± 1.0%, and non-GAAP EPS of $2.50 ± $0.15 for the fourth quarter of fiscal 2025.

Granted Patent Covers Neural Measurement of Weight, Torque and Force with Broad Applications in Brain-Computer Interfaces, Industry 4.0 and Extended Reality YOKNEAM ILLIT, ISRAEL, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced that the United States Patent and Trademark Office has officially granted the Company's patent titled “Gesture and Voice-Controlled Interface Device.

MINNEAPOLIS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that its Board of Directors has authorized the repurchase of up to $200 million of the company's outstanding shares of common stock.